Log In
BCIQ
Print this Print this
 

EG-12

  Manage Alerts
Collapse Summary General Information
Company enGene Inc.
DescriptionDNA carrying interleukin-10 (IL-10) delivered to the gut
Molecular Target Interleukin-10 (IL-10)
Mechanism of Action 
Therapeutic ModalityNucleic acid
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis (UC)
Regulatory Designation
PartnerJohnson & Johnson

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$341.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/14/2015

Undisclosed

Undisclosed

$341.5M

Get a free BioCentury trial today